Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-197.12M
↓ 135% below average
Average (9y)
$-83.87M
Historical baseline
Range
High:$141.44M
Low:$-197.12M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-197.12M | -14.8% |
| 2023 | $-171.75M | -70.5% |
| 2022 | $-100.76M | -15.7% |
| 2021 | $-87.09M | -82.2% |
| 2020 | $-47.80M | -133.8% |
| 2019 | $141.44M | +237.0% |
| 2018 | $-103.28M | +24.4% |
| 2017 | $-136.68M | +0.3% |
| 2016 | $-137.16M | -9443.0% |
| 2015 | $1.47M | - |